Journal of Shandong University (Health Sciences) ›› 2024, Vol. 62 ›› Issue (9): 30-35.doi: 10.6040/j.issn.1671-7554.0.2024.0375
• Advances in Basic and Clinical Research on Aortic Diseases-Research Progress • Previous Articles
GAO Jianfeng1, LI Fangda1, WU Lianglin1, ZENG Rong1, ZHENG Yuehong1,2
CLC Number:
[1] Kadian-Dodov D, Seo P, Robson PM,et al. Inflammatory diseases of the aorta: JACC focus seminar, part 2[J]. J Am Coll Cardiol, 2022, 80(8): 832-844. [2] Gravanis MB. Giant cell arteritis and Takayasu aortitis: morphologic, pathogenetic and etiologic factors[J]. Int J Cardiol, 2000, 75(1): 21-33. [3] Saadoun D, Vautier M, Cacoub P. Medium- and large-vessel vasculitis[J]. Circulation, 2021, 143(3): 267-282. [4] Zhang X, Li Y, Zheng YH. Diffuse aortoiliac occlusion with formation of extensive collateral circulation in Takayasus arteritis[J]. Eur Heart J, 2019, 40(41): 3439. doi:10.1093/eurheartj/ehz289. [5] Joseph G, Goel R, Thomson VS, et al. Takayasu arteritis: JACC focus seminar 3/4[J]. J Am Coll Cardiol, 2022: S0735-S1097(22)07305-3. doi:10.1016/j.jacc.2022.09.051. [6] Soulages A, Sibon I, Vallat JM, et al. Neurologic manifestations of giant cell arteritis[J]. J Neurol, 2022, 269(7): 3430-3442. [7] Kaymakci MS, Boire NA, Bois MC, et al. Persistent aortic inflammation in patients with giant cell arteritis[J]. Autoimmun Rev, 2023, 22(9): 103411. doi:10.1016/j.autrev.2023.103411. [8] Ishikawa K. Diagnostic approach and proposed criteria for the clinical diagnosis of Takayasus arteriopathy[J]. J Am Coll Cardiol, 1988, 12(4): 964-972. [9] de Souza AWS, de Carvalho JF. Diagnostic and classification criteria of Takayasu arteritis[J]. J Autoimmun, 2014, 48/49: 79-83. doi:10.1016/j.jaut.2014.01.012. [10] Ponte C, Grayson PC, Robson JC, et al. 2022 American College of Rheumatology/EULAR classification criteria for giant cell arteritis[J]. Ann Rheum Dis, 2022, 81(12): 1647-1653. [11] Ben-Shoshan J, Zahler D, Steinvil A, et al. Extracranial carotid artery stenosis and outcomes of patients undergoing transcatheter aortic valve replacement[J]. Int J Cardiol, 2017, 227: 278-283. doi:10.1016/j.ijcard.2016.11.107. [12] Li J, Wang YH, Wang YH, et al. Association between acute phase reactants, interleukin-6, tumor necrosis factor-α, and disease activity in Takayasus arteritis patients[J]. Arthritis Res Ther, 2020, 22(1): 285. doi:10.1186/s13075-020-02365-y. [13] Andel PM, Chrysidis S, Geiger J, et al. Diagnosing giant cell arteritis: a comprehensive practical guide for the practicing rheumatologist[J]. Rheumatol Oxf Engl, 2021, 60(11): 4958-4971. [14] Quinn KA, Ahlman MA, Malayeri AA, et al. Comparison of magnetic resonance angiography and 18F-fluorodeoxyglucose positron emission tomography in large-vessel vasculitis[J]. Ann Rheum Dis, 2018, 77(8): 1165-1171. [15] Bardi M, Diamantopoulos AP. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice summary[J]. Radiol Med, 2019, 124(10): 965-972. [16] 蔡丹杰, 迪丽比热·阿迪力, 石洪成. 18F-FDG全身PET/CT 2小时显像探测大动脉炎病灶的价值[J]. 中华核医学与分子影像杂志, 2022, 42(8): 462-466. CAI Danjie, Dilibire Adili, SHI Hongcheng. Value of 18F-FDG total-body PET/CT 2-hour imaging in detection of Takayasu arteritis[J]. Chinese Journal of Nuclear Medicine and Molecular Imaging, 2022, 42(8): 462-466. [17] Badawi RD, Shi HC, Hu PC, et al. First human imaging studies with the EXPLORER total-body PET scanner[J]. J Nucl Med, 2019, 60(3): 299-303. [18] 姜林娣,马莉莉,薛愉,等.大动脉炎诊疗规范[J].中华内科杂志, 2022, 61(5): 517-524. JIANG Lindi, MA Lili, XUE Yu, et al. Recommendations of diagnosis and treatment of Takayasus arteritis in China[J]. Chinese Journal of Internal Medicine, 2022, 61(5): 517-524. [19] Monti S, águeda AF, Luqmani RA, et al. Systematic literature review informing the 2018 update of the EULAR recommendation for the management of large vessel vasculitis: focus on giant cell arteritis[J]. RMD Open, 2019, 5(2): e001003. doi:10.1136/rmdopen-2019-001003. [20] Hellmich B, Agueda A, Monti S, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis[J]. Ann Rheum Dis, 2020, 79(1): 19-30. [21] Maz M, Chung SA, Abril A, et al. 2021 American College of Rheumatology/Vasculitis Foundation Guideline for the management of giant cell arteritis and takayasu arteritis[J]. Arthritis Rheumatol, 2021, 73(8): 1349-1365. [22] Kwon OC, Oh JS, Park MC, et al. Statins reduce relapse rate in Takayasu arteritis[J]. Int J Cardiol, 2019, 287: 111-115. doi:10.1016/j.ijcard.2019.02.046. [23] Espitia O, Bruneval P, Assaraf M, et al. Long-term outcome and prognosis of noninfectious thoracic aortitis[J]. J Am Coll Cardiol, 2023, 12, 82(11): 1053-1064. [24] Chaigne-Delalande S, de Menthon M, Lazaro E, et al. Giant-cell arteritis and Takayasu arteritis: epidemiological, diagnostic and treatment aspect s[J]. Presse Med, 2012, 41(10): 955-65. [25] Peng M, Ji W, Jiang X, et al. Selective stent placement versus balloon angioplasty for renovascular hypertension caused by Takayasu arteritis: Two-year results[J]. Int J Cardiol, 2016, 15, 205: 117-123. doi:10.1016/j.ijcard.2015.12.006. [26] Gülcü A, Gezer NS, Akar S, et al. Long-term follow-up of endovascular repair in the management of arterial stenosis caused by Takayasus arteritis[J]. Ann Vasc Surg, 2017, 42: 93-100. doi:10.1016/j.avsg.2016.10.066. [27] Jung JH, Lee YH, Song GG, et al. Endovascular versus open surgical intervention in patients with Takayasus arteritis: a meta-analysis[J]. Eur J Vasc Endovasc Surg, 2018, 55(6): 888-899. [28] Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al. 2022 ACC/AHA guideline for the diagnosis and management of aortic disease: a report of the American Heart Association/American College of Cardiology Joint Committee on clinical practice guidelines[J]. Circulation, 2022, 146(24): e334-e482. [29] Mirouse A, Biard L, Comarmond C, et al. Overall survival and mortality risk factors in Takayasus arteritis: a multicenter study of 318 patients[J]. J Autoimmun, 2019, 96: 35-39. doi:1016/j.jaut.2018.08.001. [30] Saadoun D, Lambert M, Mirault T, et al. Retrospective analysis of surgery versus endovascular intervention in Takayasu arteritis: a multicenter experience[J]. Circulation, 2012, 125(6): 813-819. [31] Joseph G, Thomson VS, Attumalil TV, et al. Outcomes of percutaneous intervention in patients with Takayasu arteritis[J]. J Am Coll Cardiol, 2023, 81(1): 49-64. [32] Espitia O, Bruneval P, Assaraf M, et al. Long-term outcome and prognosis of noninfectious thoracic aortitis[J]. J Am Coll Cardiol, 2023, 82(11): 1053-1064. [33] Wu L, Li F, Sun X, et al. Long term outcomes and potential risk factors for endovascular repair of aortic pseudoaneurysms in vascular Behçets disease[J]. Eur J Vasc Endovasc Surg, 2023, 66(2): 169-177. [34] International Study Group for Behçets Disease. Criteria for diagnosis of Behçets disease [J]. Lancet, 1990, 335(8697): 1078-1080. [35] Kwon TW, Park SJ, Kim HK, et al. Surgical treatment result of abdominal aortic aneurysm in Behçets disease[J]. Eur J Vasc Endovasc Surg, 2008, 35(2): 173-180. [36] Mousa A, Hanbal I, Sharabi A, et al. Vascular suture line wrapping for Aortoiliac anastomoses following open surgical repair of Infrarenal Behçets Aortoiliac aneurysms[J]. Orphanet J Rare Dis, 2019, 14(1): 81. doi:10.1186/s13023-019-1048-y. |
[1] | . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2016, 54(3): 91-94. |
[2] | LI Zi, ZHANG Xuping, JIAO Haimiao, LIU Luqi. Detection of cross-linking degree in artificial aeart valves with amine-specific fluorescent probe [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2014, 52(12): 1-4. |
[3] | ZHANG Xu-ping, ZHANG Dong, LI Zi, LIU Lu-qi. Research on the relationship between diabetes mellitus and in-situ saphenous vein disease [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2013, 51(11): 66-70. |
[4] |
ZHANG Dong, ZHANG Jun, LIU Lu-qi.
Research on the properties of allogenic arteries cross-linked by dye-mediated photooxidation and Genipin [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2012, 50(10): 41-. |
[5] | ZHONG Zhen-yue , WANG Mo, GAO Bin-bin, DONG Dian-ning, ZHANG Shi-yi , SUN Yan. Experience of emergency surgery on ruptured abdominal aortic aneurysm(a report of 19 Cases) [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(8): 111-. |
[6] |
.
Outcome of surgical repair with a stented elephant trunk for aortic dissection [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(10): 91-93. |
[7] | GU Zhi-tao,LIU Lu-qi. Anti-calcification function property of allogenic arteries cross-linked by dye0mediated photooxidation [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(10): 1050-1053. |
[8] | GAN Qiqing, LIU Xianhu, GOU Yuan, YANG Bin. Diagnosis and treatment of aortic dissection combined with paraplegia: a report of two cases and literature review [J]. Journal of Shandong University (Health Sciences), 2024, 62(8): 101-106. |
[9] | LIN Changpo, FU Weiguo. Progress in diagnosis and treatment of Stanford type B aortic dissection [J]. Journal of Shandong University (Health Sciences), 2024, 62(9): 7-12. |
[10] | WANG Lunchang, QIN Qi, SHU Chang. Advances in diagnosis and treatment of traumatic type B aortic dissection [J]. Journal of Shandong University (Health Sciences), 2024, 62(9): 19-25. |
[11] | WANG Zhenhua, SONG Han,WEI Duoliang, LI Bowen, XU Kai, FANG Changcun, ZHAO Xin. Early remodeling of the proximal aorta after Castor single-branched stent-graft implantation for acute type B aortic dissection [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 36-42. |
|